Choledochal Cysts: In Brief with Dr. Alexander Bondoc
Inside this episode
Kai, the Library's AI content creator,
listened to this episode and mapped who's speaking, the chapters,
key claims, and cases. Every item links to the exact moment in the
recording.
AI-enriched
Inside this episode
Who's speaking
- Speaker 1 — guest
- Dr. Alexander Bondoc — guest
Chapters
- 0:00Introduction and Classification — Introduction to choledochal cysts as congenital biliary dilation, overview of Todani classification types 1-5, and discussion of epidemiology showing higher incidence in Eastern Asia.
- 3:00Clinical Presentation and Workup — Presenting symptoms by age (incidental findings in infants, cholangitis symptoms in children), diagnostic approach including ultrasound and labs, importance of liver biopsy in neonates to rule out cystic biliary atresia, and role of MRCP for operative planning.
- 7:23Indications for Surgery and Preoperative Planning — Discussion of malignancy risk (up to 26%), need for surgical resection to prevent cholangitis and cholangiocarcinoma, timing considerations for acute versus incidental presentations, and preoperative evaluation including MRCP and ERCP.
- 12:08Surgical Technique and Postoperative Management — Detailed surgical approach by cyst type, Roux-en-Y hepaticojejunostomy reconstruction technique with 15-20 cm limb and interrupted absorbable suture, postoperative care including NG tube and biliary drains, complications including anastomotic stricture and recurrent cholangitis, and emphasis on lifelong surveillance.
Key claims
- 0:00Choledochal cysts are a congenital dilation of the biliary tree — Speaker 1
- 1:14Choledochal cysts have a female predominance — Speaker 1
- 1:22In the Western world the incidence is about one in 100,000 — Speaker 1
- 1:35In Asia specifically Eastern Asia the incidence is one in 13,000 — Speaker 1
- 1:48The Todani classification categorizes choledochal cysts as types one through five — Speaker 1
- 2:05Types one and four are likely embryologic relating to the pancreaticobiliary duct junction also known as pancreaticobiliary malunion — Speaker 1
- 2:35In adults the common channel is supposed to be less than 0.9 centimeters — Speaker 1
- 2:50In the pediatric patient any common channel is abnormal — Speaker 1
- 2:58Type 5 cyst otherwise known as Caroli's disease has an associated genetic gene mutation in PKHD1 — Speaker 1
- 3:18Type 1 is a dilation of the common bile duct only, the extrahepatic common bile duct only and that can either be fusiform or saccular — Speaker 1
- 3:45Type 2 choledochal cyst is just a small diverticulum off of the common bile duct — Speaker 1
- 3:58Type 3 or a choledochocele is a dilation of the common bile duct in the wall of the duodenum — Speaker 1
- 4:12Type 4a is a multitude of cysts both in the intra and extrahepatic biliary tree — Speaker 1
- 4:28Type 4b are multiple cysts but in the extrahepatic biliary tree only — Speaker 1
- 4:40Type 5 otherwise known as Caroli's disease has diffuse cystic dilation — Speaker 1
- 4:55In younger children such as infants choledochal cysts are often diagnosed incidentally on axial imaging or ultrasound imaging — Speaker 1
- 5:18In children patients often get symptoms consistent with cholangitis such as jaundice or fever — Speaker 1
- 5:35Patients can have a palpable right upper quadrant mass — Speaker 1
- 5:45Giant cysts that children are born with can actually perforate and present with biliary ascites — Speaker 1
- 6:05Large choledochal cysts can be identified on a 20-week fetal ultrasound — Speaker 1
- 6:18If a cyst was diagnosed prenatally and it was larger than four and a half centimeters at the 20-week anatomy scan there was a higher rate of postnatal symptomatology — Speaker 1
- 6:50In infants a liver biopsy is needed to rule out the cystic biliary atresia variant — Speaker 1
- 7:08Axial imaging such as a CT scan is needed before taking these kids to the operating room — Speaker 1
- 7:23MRCP may be useful for operative planning if there are questions about anatomic details specifically high disease into the hilum or intrahepatic — Speaker 1
- 7:50Up to 15 to 20 percent of patients have some kind of variant biliary tract anatomy — Speaker 1
- 8:03The risk for developing cholangiocarcinoma can be as high as 26 percent — Dr. Alexander Bondoc
- 8:22Even after surgical resection of these cysts some studies suggest there is still about a four percent lifetime risk of malignancy — Dr. Alexander Bondoc
- 8:45Patients presenting acutely can have pancreatitis or cholangitis — Dr. Alexander Bondoc
- 8:58For type 1 and type 4 cysts the goal is to remove as much of the duct as possible taking the duct all the way down to where it tapers behind the head of the pancreas or into the head of the pancreas — Dr. Alexander Bondoc
- 9:40Reconstruction can include a hepaticoduodenostomy or a hepaticojejunostomy — Dr. Alexander Bondoc
- 12:08For Roux-en-Y hepaticojejunostomy reconstruction, go about 15 to 20 centimeters distal from the ligament of Treitz — Speaker 1
- 12:30Perform hepaticojejunostomy with interrupted absorbable suture, usually 5-0 or 6-0 Maxon — Speaker 1
- 12:48Type 2 choledochal cysts require a resection of the diverticulum and a primary repair of the common bile duct — Speaker 1
- 13:08For type 3 cysts ERCP and sphincterotomy can be therapeutic in some cases — Speaker 1
- 13:25If type 3 lesion is large and obstructing the common duct you have to go transduodenal to resect the cyst — Speaker 1
- 13:48Type 5 may require a liver transplant if the cystic disease is diffuse throughout the liver — Speaker 1
- 14:10If the cystic burden in type 5 is limited to one side of the hemi liver you can address it surgically with a liver resection — Speaker 1
- 14:35Postoperatively patients have an NG tube for about 24 hours to protect the new jejunal anastomosis — Speaker 1
- 14:55Patients have temporary biliary drains until they're eating a regular diet to catch any leaks from the hepaticojejunostomy — Speaker 1
- 15:18Postoperative complications include recurrent cholangitis due to the connection between the biliary tree and the enteric system — Speaker 1
- 15:40Surgical complications can include anastomotic stricture, small bowel obstruction, and reflux gastritis — Speaker 1
- 15:58Prophylactically patients are put on Bactrim postoperatively — Speaker 1
Open questions
- Why is there a higher incidence of choledochal cysts in the Far East beyond pancreaticobiliary malunion theory?
- What is the optimal timing for intervention in prenatally diagnosed cysts larger than 4.5 cm at 20-week anatomy scan?
Topic overview
This discussion covers choledochal cysts, a congenital dilation of the biliary tree with female predominance and higher incidence in Eastern Asia (1 in 13,000) versus the Western world (1 in 100,000). The speakers review the Todani classification (types 1-5), emphasizing that types 1 and 4 likely relate to pancreaticobiliary malunion, while type 5 (Caroli's disease) has a genetic mutation in PKHD1. Surgical resection is the definitive treatment to prevent cholangitis, biliary cirrhosis, and cholangiocarcinoma (up to 26% risk), with reconstruction typically via Roux-en-Y hepaticojejunostomy. Lifelong surveillance remains necessary due to persistent malignancy risk (approximately 4%) even after resection.
Key takeaways
- Choledochal cysts carry up to 26% cholangiocarcinoma risk; resection is mandatory, yet 4% malignancy risk persists lifelong. (8:03)
- Type 1/4 cysts require complete duct excision to pancreatic taper, then Roux-en-Y hepaticojejunostomy with 5-0/6-0 absorbable suture. (8:58)
- In pediatric patients any common channel is abnormal (vs. adult threshold <0.9 cm), signaling pancreaticobiliary malunion. (2:05)
- Fetal cysts >4.5 cm at 20-week scan predict higher postnatal symptom rates; giant cysts can perforate causing biliary ascites. (5:45)
- Type 5 (Caroli's) stems from PKHD1 mutation; diffuse disease may require transplant, focal disease permits hemi-hepatectomy. (2:58)
Keywords
Hashtags
Transcript
Click "Show Transcript" to view the full text (13845 characters)
Comments